Alfasigma acquires the European license for bentracimab from PhaseBio
The agreement covers the countries of the European Union, the European Economic Area, the United Kingdom, Ukraine, Russia and the CIS. Bentracimab is a human monoclonal antibody fragment to counterac...
Read more